Literature DB >> 14757114

Acute systemic toxicity--prospects for tiered testing strategies.

P A Botham1.   

Abstract

After many years of controversy and debate, the LD50 test was finally deleted by the end of 2002. Three alternative animal tests, the Fixed Dose Procedure, the Acute Toxic Class Method and the Up and Down Procedure have been developed which give rise to significant improvements in animal welfare. They have recently undergone revision to improve their scientific performance but more importantly to increase their regulatory acceptance. They can now be used within a strategy for acute toxicity testing for all types of test substances and for all regulatory and in-house purposes. In vitro cytotoxicity tests could be used as adjuncts to these alternative animal tests within the next year or so to improve dose level selection and thus give further modest improvements in the numbers of animals used. However, the total replacement of animal tests requires a considerable amount of further test development, followed by validation, and is at least 10 years away.

Entities:  

Mesh:

Year:  2004        PMID: 14757114     DOI: 10.1016/s0887-2333(03)00143-7

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  25 in total

1.  Synthesis and biological evaluation of PMMA/MMT nanocomposite as denture base material.

Authors:  Junping Zheng; Qiang Su; Chen Wang; Gang Cheng; Ran Zhu; Jin Shi; Kangde Yao
Journal:  J Mater Sci Mater Med       Date:  2011-03-04       Impact factor: 3.896

2.  Possible attenuation of nitric oxide expression in anti-inflammatory effect of Ziziphus jujuba in rat.

Authors:  Rohit Goyal; Pyare Lal Sharma; Manjeet Singh
Journal:  J Nat Med       Date:  2011-04-11       Impact factor: 2.343

3.  Effects of acute doses of methylphenidate on inflammation and oxidative stress in isolated hippocampus and cerebral cortex of adult rats.

Authors:  Majid Motaghinejad; Manijeh Motevalian; Behnaz Shabab; Sulail Fatima
Journal:  J Neural Transm (Vienna)       Date:  2016-09-28       Impact factor: 3.575

4.  Predictive models for estimating cytotoxicity on the basis of chemical structures.

Authors:  Hongmao Sun; Yuhong Wang; Dorian M Cheff; Matthew D Hall; Min Shen
Journal:  Bioorg Med Chem       Date:  2020-03-12       Impact factor: 3.641

5.  Development of polyherbal antidiabetic formulation encapsulated in the phospholipids vesicle system.

Authors:  Vinod Kumar Gauttam; Ajudhia Nath Kalia
Journal:  J Adv Pharm Technol Res       Date:  2013-04

6.  A statistical evaluation of the effects of gender differences in assessment of acute inhalation toxicity.

Authors:  Charlotte Price; Nigel Stallard; Stuart Creton; Ian Indans; Robert Guest; David Griffiths; Philippa Edwards
Journal:  Hum Exp Toxicol       Date:  2010-05-20       Impact factor: 2.903

Review 7.  Cross-sector review of drivers and available 3Rs approaches for acute systemic toxicity testing.

Authors:  Troy Seidle; Sally Robinson; Tom Holmes; Stuart Creton; Pilar Prieto; Julia Scheel; Magda Chlebus
Journal:  Toxicol Sci       Date:  2010-05-19       Impact factor: 4.849

8.  Extrapolation of toxic indices among test objects.

Authors:  Miloň Tichý; Marián Rucki; Zdeněk Roth; Iveta Hanzlíková; Alena Vlková; Jana Tumová; Rút Uzlová
Journal:  Interdiscip Toxicol       Date:  2010-12

9.  Antiedematogenic Evaluation of Copaifera langsdorffii Leaves Hydroethanolic Extract and Its Major Compounds.

Authors:  Ricardo Andrade Furtado; Cristiane Teixeira Vilhena Bernardes; Mauro Nogueira da Silva; Karina Furlani Zoccal; Lúcia Helena Faccioli; Jairo Kenupp Bastos
Journal:  Biomed Res Int       Date:  2015-05-21       Impact factor: 3.411

10.  Synthesis and Evaluation of Thiol-Conjugated Poloxamer and Its Pharmaceutical Applications.

Authors:  Muhammad Zaman; Sadaf Saeed; Rabia Imtiaz Bajwa; Muhammad Shafeeq Ur Rahman; Saeed Ur Rahman; Muhammad Jamshaid; Muhammad F Rasool; Abdul Majeed; Imran Imran; Faleh Alqahtani; Sultan Alshehri; Abdullah F AlAsmari; Nemat Ali; Mohammed Alasmari
Journal:  Pharmaceutics       Date:  2021-05-11       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.